Gastroenterology

Serum concentrations of aminotransferases improved for HCC-DAA and DAA-HCC groups 1 year following surgery.

One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.

Grade 3 injection site redness led to the predefined stopping rules for 10 patients in the clinical trials.

IBS is considered 1 of the most expensive conditions in gastroenterology.

Data show patients with chronic IBS had six times the odds of developing glaucoma (OR 6.58; 95% CI, 2.00 - 16.89), in comparison to those without chronic IBS.

Despite conflicting data, investigators form Spain found that gastroesophageal reflux disease and asthma are bidirectional, with each disease exacerbating each other.

CDI patients in the RT 014-020 subgroup had better clinical outcomes.

The Firmicutes/Bacteroidetes ratio was lower for patients with sickle cell disease compared to a healthy control group.

Fluoroquinolones use within 14 days of transplantation was 1 of the strongest risk factors for C difficile infections.

Clindamycin, fluoroquinolones, and ceftriaxone are associated with the highest risk of CDI.

Serum HBV DNA significantly decreased from week 0-24 in patients treated with entecavir.

The study also showed cost savings for both standard and dose-intensified infliximab.

Both patients and physicians request more time for routine ulcerative colitis appointments.

All NOACs had a lower risk of stroke or SE compared to warfarin, including apixaban, dabigatran, and rivaroxaban.

While effective, liver biopsies are invasive and costly for assessing liver fibrosis.

In part 2 of an interview with HCPLive, Dr. Saxe focuses on the role of microbiota in pain and how concomitant conditions in patients are often nutritionally linked.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

Both Crohn’s disease and ulcerative colitis patients had a higher risk of IBD-related readmission and length of stay.

Both vedolizumab and ustekinumab are common treatments for inflammatory bowel disease.

In the study, 5.6% of patients developed a post-operative C difficile infection.

HBeAg loss rate was higher in males and older individuals.

There was not a statistically significant correlation between CDI recurrence and age, gender, previous proton pump inhibitor use, and antibiotic exposure.

There is a need for new antibiotic targets for treating C difficile infections.

The new diet program was compared to the existing front-line therapy of exclusive enteral nutrition.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.